Back
Actinium Pharmaceuticals Vs. Outlook Therapeutics Industry Stock Comparison
Buy
53
ATNM
Actinium Pharmaceuticals
Last Price:
9.68
Seasonality Move:
-2.01%
Sell
44
OTLK
Outlook Therapeutics
Last Price:
7.95
Seasonality Move:
22.9%
Buy
53
Actinium Pharmaceuticals (ATNM)
is a Buy
Is Actinium Pharmaceuticals a Buy, Sell or Hold?
- The current Actinium Pharmaceuticals [ATNM] share price is $9.80. The Score for ATNM is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- ATNM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
44
Outlook Therapeutics (OTLK)
is a Sell
Is Outlook Therapeutics a Buy, Sell or Hold?
- The current Outlook Therapeutics [OTLK] share price is $7.78. The Score for OTLK is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- OTLK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ATNM Stock Price Chart
What is Actinium Pharmaceuticals's stock price today?
-
The Actinium Pharmaceuticals share price today is $9.80
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ATNM is experiencing slight buying pressure.
OTLK Stock Price Chart
What is Outlook Therapeutics's stock price today?
-
The Outlook Therapeutics share price today is $7.78
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OTLK is experiencing buying pressure, which is a positive indicator for future bullish movement.
ATNM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.5 | Buy |
| Relative Strength Index (14 RSI): | 66.22 | Buy |
| Chaikin Money Flow: | 78855 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.1 - 9.24) | Buy |
| Bollinger Bands (100): | (5.53 - 8.61) | Buy |
OTLK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.3 | Sell |
| Relative Strength Index (14 RSI): | 44.35 | Sell |
| Chaikin Money Flow: | 115028 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.71 - 8.67) | Sell |
| Bollinger Bands (100): | (7.41 - 9.11) | Sell |
ATNM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.31 | Buy |
| 20-day SMA: | 8.37 | Buy |
| 50-day SMA: | 8.18 | Buy |
| 200-day SMA: | 6.36 | Buy |
| 8-day EMA: | 9.38 | Buy |
| 20-day EMA: | 8.78 | Buy |
| 50-day EMA: | 8.14 | Buy |
| 200-day EMA: | 7.12 | Buy |
OTLK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.6 | Buy |
| 20-day SMA: | 8.11 | Sell |
| 50-day SMA: | 8.34 | Sell |
| 200-day SMA: | 9.87 | Sell |
| 8-day EMA: | 7.68 | Buy |
| 20-day EMA: | 8.02 | Sell |
| 50-day EMA: | 8.28 | Sell |
| 200-day EMA: | 11.33 | Sell |
Actinium Pharmaceuticals Earnings Growth & ATNM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.46 per share, an increase this year of $0.45 per share, and an increase next year of $1.05 per share.
Outlook Therapeutics Earnings Growth & OTLK Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.17 per share, an increase next quarter of $0.35 per share, an increase this year of $0.49 per share, and an increase next year of $1.74 per share.
Actinium Pharmaceuticals Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Outlook Therapeutics Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||